Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR) Administered Intranasally to Healthy, Adult Volunteers
Conditions:   Shigellosis;   Bacillary DysenteryIntervention:   Biological: Shigella flexneri 2a InvaplexARSponsor:   U.S. Army Medical Research and Materiel CommandNot yet recruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 13, 2015 Category: Research Source Type: clinical trials

Safety of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition:   ShigellosisInterventions:   Biological: Flexyn2a;   Biological: Placebo;   Biological: Flexyn2a plus adjuvantSponsors:   GlycoVaxyn AG;   Wellcome Trust;   Naval Medical Research CenterActive, not recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2015 Category: Research Source Type: clinical trials

Safety of a Candidate Bioconjugate Vaccine Against Shigella Flexneri 2a
Condition:   ShigellosisInterventions:   Biological: Flexyn2a;   Biological: Placebo;   Biological: Flexyn2a plus adjuvantSponsors:   GlycoVaxyn AG;   Wellcome Trust;   Naval Medical Research CenterRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2015 Category: Research Source Type: clinical trials